Recruiting NA INTERVENTIONAL 1-arm NCT04733404

Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation

A Prospective, Multicenter, Objective Performance Criteria Study to Evaluate the Safety and Effectiveness of Dragonfly Transcatheter Mitral Valve Repair System for the Treatment of Functional Mitral Regurgitation (FMR) Subjects.

Sponsor: Hangzhou Valgen Medtech Co., Ltd

Conditions Mitral Regurgitation Functional

Interventions Dragonfly Transcatheter Mitral Valve Repair System

Updated 5 times since 2021 Last updated: Mar 26, 2022 Started: Mar 12, 2022 Primary completion: Sep 30, 2023 Completion: Sep 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Mitral Regurgitation Functional, this trial is actively recruiting participants. The trial is conducted by Hangzhou Valgen Medtech Co., Ltd and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Apr 2022 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2021 — Apr 2022 [monthly]

Not Yet Recruiting NA
Mar 2021 — Sep 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hangzhou Valgen Medtech Co., Ltd

Data source: Hangzhou Valgen Medtech Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China